A new study by researchers at Intermountain Medical Center Heart Institute found no increased risk of breast cancer in women taking calcium channel blocker medications. The study, which analyzed over 3,700 women with long-term use of the medication, showed a minimal increase in risk and a 50% reduced risk in some cases.
A new study of 5,695 men with low testosterone levels found that testosterone supplementation reduces the risk of major adverse cardiac events such as heart attacks and strokes. Men who received testosterone supplementation had lower rates of death and heart attacks compared to those with persistently low testosterone levels.
A new study by Intermountain Medical Center found that routine heart imaging screenings for diabetic patients at high risk of heart disease did not prevent heart attacks, hospitalization, or cardiac death. High-quality diabetes management remains the most effective way to avoid these events.
A new study by researchers at Intermountain Medical Center Heart Institute suggests that lifestyle choices, not just genetics, may contribute to the risk of heart attack. The study found that severe coronary artery disease can be inherited, but the presence of heart attacks in people with less severe disease was not clustered in families.
Researchers at Intermountain Medical Center developed a simple saliva test that uses a smartphone to quantify and interpret cortisol levels in five minutes. This new technology helps identify adrenal insufficiency, monitor cortisol replacement, and assess physiologic changes in adrenal function.
Researchers found that periodic fasting can convert bad cholesterol in fat cells to energy, reducing the risk of diabetes and metabolic problems. After 10-12 hours of fasting, the body starts scavenging for other sources of energy, pulling LDL cholesterol from fat cells and using it as energy.
A study by Intermountain Medical Center found that AFib patients on blood thinning medications are at higher risk of developing dementia if their doses are not within the optimal recommended range. Patients with dosages outside this range were 4.5 times more likely to develop dementia.
Researchers have identified two new protein markers, GlycA and GlycB, which are associated with inflammation and cardiovascular disease. Elevated levels of these proteins were found in nearly half of the patients who died or suffered an adverse event during follow-up.
Researchers identified plasma levels of microRNA 122 and 126 that decline before a person suffers a heart attack, suggesting these markers may help predict imminent risk. The discovery could lead to the development of a blood test to identify people at high risk of having a heart attack.
Researchers used CBC lab testing information gathered from the JUPITER Trial to evaluate the Intermountain-derived CBC risk score, finding it a powerful tool to predict death. Individuals with lower CBC risk scores were unlikely to die, while those with higher scores had more than 50% higher risk of death.
Researchers at Intermountain Medical Center Heart Institute discovered a link between high RDW levels and increased risk of depression in heart patients. Elevated RDW is associated with poor outcomes, including heart attacks and death, and may indicate anemia or other underlying conditions.
A new study by Intermountain Medical Center has discovered a simple way to further predict a diabetic patient's risk for heart disease: measuring their body mass index or BMI. The findings show that the greater the patient's BMI, the greater their risk for heart disease.
Researchers at Intermountain Medical Center have developed a real-time electronic screening tool to identify patients with pneumonia, speeding up diagnosis and treatment. The tool analyzes over 40 variables to determine the probability of pneumonia, alerting caregivers when necessary.
Researchers have identified a new alternative to statins for patients who can't tolerate the side effects of cholesterol-lowering drugs. Pitavastatin was shown to lower bad cholesterol by an average of 34% and reduce the risk of heart attack, stroke, and death in up to 68% of patients with high cholesterol.
Researchers found longer telomeres correlate with longer lives and increased survival rates among patients with heart disease. The study analyzed DNA samples from over 3,500 heart attack and stroke patients, revealing a link between telomere length and life expectancy.
Researchers developed an innovative tool, IMRS-HF, to predict 30-day hospital readmissions in heart failure patients. The tool uses a statistical model that analyzes several variables and provides a risk score for physicians, helping ensure healthier discharge conditions.
Researchers developed a tool that combines age, gender, and common blood tests to predict mortality among trauma patients. The Intermountain Risk Score identifies high-risk patients with increased likelihood of death within a year.
A series of studies by Intermountain Healthcare's Oncology Clinical Program shows that improving care across a large hospital system is possible through standardized care. Key findings include reduced mastectomies and lymph node removals in breast cancer patients, indicating a more consistent approach to treatment.
A study by Intermountain Medical Center Heart Institute has established a connection between microRNAs and impending heart attacks. Researchers identified six microRNA molecules linked to gene regulation, revealing lower levels in patients who experienced a heart attack within seven days.
Researchers developed a safer and more accurate way to administer warfarin by combining individual genetic data with a mathematical model. This new formula helps physicians determine the safest dose for each patient, potentially eliminating many emergency hospitalizations.
Researchers at Intermountain Medical Center found that patients with excess vitamin D levels had a two and a half times greater risk of developing atrial fibrillation. The study suggests that communication between patients and healthcare providers is critical to determine safe doses of vitamin supplements.
A new study by Intermountain Medical Center researchers found that heart patients taking vitamins with warfarin are less likely to take their medication as prescribed. Patients who use vitamin supplements with warfarin are more likely to experience unexplained bleeding and need non-surgical transfusions.
Researchers at Intermountain Medical Center found that fetal heart rate patterns may lead to unnecessary C-sections and increased costs. Category II patterns, considered indeterminate, are often misclassified, resulting in lower Apgar scores and NICU admissions.
A new study developed a cost-effective way to identify patients at risk for Lynch syndrome, which could lead to earlier screenings and improved outcomes for colon and other cancers. The process uses two relatively inexpensive tests to eliminate possible carriers before full genome sequencing is required.
A new process has been developed to identify patients at risk of Lynch syndrome, a genetic mutation that increases cancer risk. The process uses two inexpensive tests to eliminate possible carriers before full genome sequencing, significantly reducing costs and improving accuracy.
A recent study published in the American College of Cardiology's annual scientific sessions reveals that routine periodic fasting can lower one's risk of coronary artery disease and diabetes. Fasting was also found to reduce other cardiac risk factors, such as triglycerides, weight, and blood sugar levels.
A recent study by Intermountain Medical Center Heart Institute reveals that over half of patients taking warfarin are unaware of potential interactions with herbal and dietary supplements. The most commonly used supplements interfere with the effectiveness of warfarin, increasing the risk of bleeding or stroke.
Researchers at Intermountain Medical Center found ablation treatment significantly reduces risk of Alzheimer's disease and stroke. Atrial fibrillation patients treated with catheter ablation have lower risk of dementia and mortality compared to untreated patients.
Researchers found that treating vitamin D deficiency with supplements can reduce cardiovascular disease and other chronic conditions. Increasing vitamin D levels by 1000-5000 IU per day may be beneficial for patients at-risk.
A new risk score tool developed by researchers at Intermountain Medical Center has been shown to more accurately predict patients' risk for cardiac disease and death. The Intermountain Risk Score, which includes age, sex, and routine blood test results, improved doctors' ability to measure patient risk by up to 57%.
A recent study by researchers at Intermountain Medical Center found that patients with low levels of vitamin D were more likely to develop coronary artery disease, heart failure, and stroke. The study followed 27,686 patients over a year and found that those with very low levels of vitamin D were 77% more likely to die.
Researchers at Intermountain Medical Center discovered a strong relationship between atrial fibrillation and the development of Alzheimer's disease in a study of over 37,000 patients. Patients with atrial fibrillation were 44% more likely to develop dementia than those without, with younger patients facing higher risks.